HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William M Wuest Selected Research

Pseudomonas Infections

3/2020Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William M Wuest Research Topics

Disease

11Infections
02/2024 - 10/2017
4Neoplasms (Cancer)
01/2021 - 01/2018
3AIDS-Related Complex (ARC)
12/2008 - 01/2008
2Wounds and Injuries (Trauma)
06/2023 - 01/2017
2Cystic Fibrosis (Mucoviscidosis)
03/2020 - 01/2019
1Acne Vulgaris
01/2023
1Inflammation (Inflammations)
01/2023
1COVID-19
04/2021
1Coinfection
04/2021
1Bacterial Infections (Bacterial Infection)
04/2021
1Pseudomonas Infections
03/2020
1Persistent Infection
01/2020
1Breast Neoplasms (Breast Cancer)
09/2019
1Staphylococcal Infections
01/2019
1Gram-Positive Bacterial Infections
01/2018
1Reinfection
01/2018

Drug/Important Bio-Agent (IBA)

11Anti-Bacterial Agents (Antibiotics)IBA
08/2021 - 10/2017
3AnionsIBA
12/2008 - 01/2008
2RetinoidsIBA
01/2023 - 01/2018
2Gentamicins (Gentamicin)FDA LinkGeneric
01/2019 - 01/2018
1Ammonium CompoundsIBA
02/2024
1Disinfectants (Biocides)IBA
02/2024
1Quaternary Ammonium CompoundsIBA
02/2024
1HydrogelsIBA
06/2023
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2023
1Interleukin-6 (Interleukin 6)IBA
01/2023
1CytokinesIBA
01/2023
1Adapalene (Differin)FDA LinkGeneric
01/2023
1InterleukinsIBA
01/2023
1Interleukin-8 (Interleukin 8)IBA
01/2023
1Tetracycline (Achromycin)FDA LinkGeneric
01/2023
1AdamantaneIBA
03/2020
1AlginatesIBA
01/2020
1Phosphotransferases (Kinase)IBA
09/2019
1MLN 8237IBA
09/2019
1Phenobarbital (Luminal)FDA Link
09/2019
1p21-Activated KinasesIBA
09/2019
1Aurora Kinase AIBA
09/2019
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2019
1Virulence Factors (Pathogenicity Factors)IBA
04/2019
1ProdrugsIBA
01/2019
1Bithionol (Bitin)IBA
01/2019
1ulbactin FIBA
01/2018
1Lipid Bilayers (Lipid Bilayer)IBA
01/2018
14- (6- hydroxy- 7- tricyclo(3.3.1.13,7)dec- 1- yl- 2- naphthalenyl)benzoic acidIBA
01/2018
1dithianeIBA
12/2008
1Epoxy Compounds (Epoxides)IBA
12/2008
1CarbonIBA
12/2008
1o-trimethylsilylbenzaldehydeIBA
01/2008

Therapy/Procedure

3Therapeutics
04/2021 - 01/2018
1Catheters
01/2017